nested PCR | GenomeWeb

nested PCR

The award will go to David Alland to create an Ebola test using the same technology as a TB assay marketed by Cepheid.

Rusinga Island, via Wikimedia Commons.

The new method detects very low levels of parasitemia which could be useful for future malaria erradication efforts.

BioMérieux's BioFire Diagnostics subsidary and Cepheid sponsored presentations at the American Association for Molecular Pathology annual meeting in which clinical users shared preliminary data on highly anticipated products from the companies.

NEW YORK (GenomeWeb) – An international team of tropical medicine researchers has developed a forensic procedure that can accurately identify the culprit in approximately one in four cases of snakebite.

NEW YORK (GenomeWeb) — An Italian research group has developed a direct PCR-based approach for more simple and accessible pharmacogenomic testing to determine whether HIV patients carry the HLA-B*5701 marker associated with risk of serious side effects to the antiretroviral drug abacavir.

NEW YORK (GenomeWeb) — ATCC has partnered with the US Centers for Disease Control and Prevention and Thermo Fisher Scientific's Life Technologies, among other organizations, to manufacture and distribute a rapid, cost-effective genotyping kit to monitor HIV-1 drug resistance in resource-limited c

In Cambodia's Ratanakiri Province, main roads project like spokes from the small city of Banlung, population 17,000. Here, next to the local health department, a team of Cambodian and Belgian researchers intent on eliminating malaria parked a mobile PCR lab last fall.

Cepheid's Xpert CT/NG assay for detecting Chlamydia trahcomatis and Neisseria gonorrhoeae is at least as accurate as two other commercially available molecular tests for the bacteria, according to the recently published results of the beta phase of a multi-center clinical

Danish diagnostic technology developer Atonomics has published a paper describing its proprietary nested PCR technology and has demonstrated its ability to simultaneously detect multiple yeast and bacterial nucleic acid targets more quickly, and with a lower limit of detection, t

Cepheid today unveiled a slew of innovations that it is developing for its flagship GeneXpert platform to help it move beyond infectious disease diagnostics and increase its presence in the oncology, epidemiology, and biodefense markets.


In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.